1. Home
  2. WLFC vs MDXG Comparison

WLFC vs MDXG Comparison

Compare WLFC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willis Lease Finance Corporation

WLFC

Willis Lease Finance Corporation

N/A

Current Price

$178.45

Market Cap

1.3B

ML Signal

N/A

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$4.55

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WLFC
MDXG
Founded
1985
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
WLFC
MDXG
Price
$178.45
$4.55
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$10.00
AVG Volume (30 Days)
25.3K
746.7K
Earning Date
06-22-2026
01-01-0001
Dividend Yield
0.92%
N/A
EPS Growth
146.23
14.29
EPS
13.89
0.32
Revenue
$569,223,000.00
$418,630,000.00
Revenue This Year
$16.17
N/A
Revenue Next Year
$1.26
$13.14
P/E Ratio
$12.53
$14.20
Revenue Growth
36.00
19.99
52 Week Low
$114.01
$4.37
52 Week High
$207.05
$8.13

Technical Indicators

Market Signals
Indicator
WLFC
MDXG
Relative Strength Index (RSI) 43.10 28.22
Support Level $129.37 N/A
Resistance Level $189.45 $5.38
Average True Range (ATR) 7.62 0.19
MACD -4.12 -0.03
Stochastic Oscillator 32.34 16.06

Price Performance

Historical Comparison
WLFC
MDXG

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: